Quinoline-8-sulfonamide

Catalog No. :
ACRUMP450
CAS No. :
35203-91-9
Molecular Formula :
C9H8N2O2S
Molecular Weight :
208.24

IUPAC Name:quinoline-8-sulfonamide

Quinoline-8-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$62.00Login to see priceIn stockInquiry
1g95%$123.00Login to see priceIn stockInquiry
5g95%$602.00Login to see priceIn stockInquiry
25g95%$2709.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameQuinoline-8-sulfonamide
IUPAC Namequinoline-8-sulfonamide
MDL No.0
Molecular FormulaC9H8N2O2S
Molecular Weight208.24
SMILESO=S(C1=C2N=CC=CC2=CC=C1)(N)=O
InChI KeyZTYZEUXZHGOXRT-UHFFFAOYSA-N
Synonym3-((2-Chloro-5-thiazolyl)methyl)tetrahydro-5-methyl-N-nitro-4H-1,3,5-oxadiazin-4-imine | MFCD01191906 | quinoline-8-sulfonamide | HMS2220E20 | MLS000070229 | SR-01000596881 | BDBM50125190 | Benzeneacetonitrile, .alpha.-[[[(1,1-dimethylethoxy)carbonyl]oxy]
CAS No.35203-91-9
PubChem CID94464

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRUMP450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRUMP450 route product structure diagram
    ACRUMP45035203-91-9 In Stock
Inquiry

2. ACRUMP450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRUMP450 route product structure diagram
    ACRUMP45035203-91-9 In Stock
Inquiry

Comments (0)